BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ClinStar to Be Featured on Business Day TV With Terry Bradshaw


12/9/2011 9:22:49 AM

SAN FRANCISCO, Dec. 8, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in the emerging markets of Russia and Eastern Europe to the biopharmaceutical industry, announced today that it is being featured in a Medical Minutes series by Business Day TV hosted by Terry Bradshaw.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/clinstar-to-be-featured-on-business-day-tv-with-terry-bradshaw-135250298.html

According to the episode, it takes approximately 10 to 15 years and over one billion dollars to launch a new drug, and even then, only one in five products generate enough revenue to break-even. To speed up the process, biopharmaceutical companies utilize the services of Contract Research Organizations (CROs) to conduct the clinical research phase in patients. However, with qualified and interested patients becoming more difficult to find in the West, the industry is turning to CROs like ClinStar that geographically specialize in emerging markets.

"More and more clinical research is being conducted outside the traditional markets of North America and Western Europe," says David Passov, President and CEO of ClinStar. "This is not necessarily driven only by somewhat lower cost but rather by the ability to significantly speed up drug development by accessing a global population of 7 billion people."

Specializing in the emerging markets of Russia, Ukraine, Belarus and the Baltic States, ClinStar leverages the region's combined population of over 200 million and the support of physicians and government regulatory bodies to enjoy recruitment rates up to 20 times faster than in the West.

"By conducting clinical trials in emerging markets, biopharmaceutical organizations are able to reduce the time to develop a drug," says Mr. Passov. "This not only translates into cost savings for the biopharmaceutical industry but results in faster access to better medicines for us all."

View the full-length version of ClinStar featured on Business Day TV

Contact:
Heather Newbold
919-354-3573 ext. 276
heather.newbold@clinstar.com

About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.

SOURCE ClinStar, LLC


Read at BioSpace.com


ClinStar
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->